Qualis Innovations, Inc. announced that on January 23, 2023, Dr. Robert Bilkovski, the Chief Scientific Officer of the company, notified the Company of his decision to resign, effective immediately, from any and all offices he may hold with the Company, including Chief Scientific Officer of the Company. Dr. Bilkovski's resignation was to pursue other business opportunities and did not result from any disagreement with the Company, the Company's Board of Directors, or the Company's management on any matter relating to the Company's operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.263 USD | 0.00% | 0.00% | -12.36% |
1st Jan change | Capi. | |
---|---|---|
-12.36% | 5.38M | |
-1.46% | 2,930B | |
+27.05% | 63.75B | |
+3.36% | 15.98B | |
-26.61% | 5.32B | |
+2.97% | 3.61B | |
+81.08% | 1.15B | |
+29.51% | 808M | |
+9.96% | 343M | |
+47.83% | 120M |
- Stock Market
- Equities
- QLIS Stock
- News Qualis Innovations, Inc.
- Qualis Innovations, Inc. Announces Resignation of Dr. Robert Bilkovski as Chief Scientific Officer